https://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/news/European-Medicines-Agency-Validates-Bristol-Myers-Squibb-s-Application-for-Repotrectinib-for-the-T-45658019/?utm_source=telegram&utm_medium=social&utm_campaign=share